Biodegradation of pharmaceutical contaminants in wastewater using microbial consortia: Mechanisms, applications, and challenges

IF 8 2区 环境科学与生态学 Q1 ENVIRONMENTAL SCIENCES
Fatmata Sesay , Richard Edmond Victor Sesay , Musa Kamara , Xuesong Li , Chengxin Niu
{"title":"Biodegradation of pharmaceutical contaminants in wastewater using microbial consortia: Mechanisms, applications, and challenges","authors":"Fatmata Sesay ,&nbsp;Richard Edmond Victor Sesay ,&nbsp;Musa Kamara ,&nbsp;Xuesong Li ,&nbsp;Chengxin Niu","doi":"10.1016/j.jenvman.2025.125564","DOIUrl":null,"url":null,"abstract":"<div><div>Pharmaceuticals, including non-steroidal anti-inflammatory drugs and antibiotics, have been increasingly detected in wastewater and pose substantial ecological and public health concerns due to their persistence and bioactivity. Conventional treatment processes are often insufficient for their complete removal, highlighting the need for advanced bioremediation strategies. This review critically examines the mechanisms, applications, and challenges of microbial consortia for pharmaceutical biodegradation. It emphasizes their synergistic metabolic pathways, such as cross-feeding, co-metabolism, and enzymatic cascades, that enable efficient degradation of complex contaminants. Recent advancements, such as membrane bioreactors, bioaugmentation with genetically engineered consortia, and integrated systems coupling microbial processes with advanced oxidation processes, are reviewed for their potential to enhance treatment efficacy, scalability, and sustainability. Comparative analysis underscores microbial consortia's superiority over single-strain systems and adsorption techniques in treating complex contaminant mixtures, achieving up to 100 % removal efficiency for specific compounds. Persistent challenges include microbial community instability, the toxicity of transformation products, and regulatory constraints related to genetically modified organisms. Strategic solutions are proposed, such as pilot-scale implementation of tailored consortia, Internet of things (IoT)-enabled real-time monitoring, and circular economy approaches for resource recovery. By addressing these challenges, microbial consortia-based biodegradation emerges as a transformative solution for pharmaceutical wastewater treatment, aligning with global sustainability goals. This review provides actionable insights for optimizing bioremediation frameworks, informing policy, and advancing research in environmental microbiology and wastewater engineering.</div></div>","PeriodicalId":356,"journal":{"name":"Journal of Environmental Management","volume":"384 ","pages":"Article 125564"},"PeriodicalIF":8.0000,"publicationDate":"2025-04-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Environmental Management","FirstCategoryId":"93","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0301479725015403","RegionNum":2,"RegionCategory":"环境科学与生态学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ENVIRONMENTAL SCIENCES","Score":null,"Total":0}
引用次数: 0

Abstract

Pharmaceuticals, including non-steroidal anti-inflammatory drugs and antibiotics, have been increasingly detected in wastewater and pose substantial ecological and public health concerns due to their persistence and bioactivity. Conventional treatment processes are often insufficient for their complete removal, highlighting the need for advanced bioremediation strategies. This review critically examines the mechanisms, applications, and challenges of microbial consortia for pharmaceutical biodegradation. It emphasizes their synergistic metabolic pathways, such as cross-feeding, co-metabolism, and enzymatic cascades, that enable efficient degradation of complex contaminants. Recent advancements, such as membrane bioreactors, bioaugmentation with genetically engineered consortia, and integrated systems coupling microbial processes with advanced oxidation processes, are reviewed for their potential to enhance treatment efficacy, scalability, and sustainability. Comparative analysis underscores microbial consortia's superiority over single-strain systems and adsorption techniques in treating complex contaminant mixtures, achieving up to 100 % removal efficiency for specific compounds. Persistent challenges include microbial community instability, the toxicity of transformation products, and regulatory constraints related to genetically modified organisms. Strategic solutions are proposed, such as pilot-scale implementation of tailored consortia, Internet of things (IoT)-enabled real-time monitoring, and circular economy approaches for resource recovery. By addressing these challenges, microbial consortia-based biodegradation emerges as a transformative solution for pharmaceutical wastewater treatment, aligning with global sustainability goals. This review provides actionable insights for optimizing bioremediation frameworks, informing policy, and advancing research in environmental microbiology and wastewater engineering.
利用微生物群落对废水中药物污染物的生物降解:机制、应用和挑战
药物,包括非甾体抗炎药和抗生素,越来越多地在废水中被检测到,由于它们的持久性和生物活性,造成了严重的生态和公共卫生问题。传统的处理工艺往往不足以完全去除它们,因此需要先进的生物修复策略。这篇综述严格审查的机制,应用和挑战的微生物财团的药物生物降解。它强调它们的协同代谢途径,如交叉喂养,共同代谢和酶级联反应,使复杂污染物的有效降解成为可能。最近的进展,如膜生物反应器,生物增强与基因工程联合体,集成系统耦合微生物过程与高级氧化过程,回顾了他们的潜力,以提高处理效果,可扩展性和可持续性。对比分析强调了微生物联合体在处理复杂污染物混合物方面优于单菌株系统和吸附技术,对特定化合物的去除率高达100%。持续的挑战包括微生物群落的不稳定性、转化产物的毒性以及与转基因生物相关的监管限制。提出了战略解决方案,如试点规模实施量身定制的联盟,支持物联网(IoT)的实时监控以及资源回收的循环经济方法。通过应对这些挑战,基于微生物联合体的生物降解成为制药废水处理的变革性解决方案,与全球可持续发展目标保持一致。这一综述为优化生物修复框架、为政策提供信息以及推进环境微生物学和废水工程的研究提供了可行的见解。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of Environmental Management
Journal of Environmental Management 环境科学-环境科学
CiteScore
13.70
自引率
5.70%
发文量
2477
审稿时长
84 days
期刊介绍: The Journal of Environmental Management is a journal for the publication of peer reviewed, original research for all aspects of management and the managed use of the environment, both natural and man-made.Critical review articles are also welcome; submission of these is strongly encouraged.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信